EUVIMEDEUVIMED entdecken
Klinische StudieVergleichsstudieKohortenstudieOpen Access

Patient Experience of Withdrawal During Methadone–Buprenorphine Transfer: A Prospective Cohort Study

Chris Tremonti iD, Llewellyn Mills, Nicholas Lintzeris, James Blogg iD, Nazila Jamshidi, Ricky Harjanto, Alison Blazey, Mark Montebello iD, Charlotte Ismay, Robert Page iD, Nicholas A Buckley, Varan Perananthan iD und 1 weitere

Drug and Alcohol Review · 2026-07 · 45 (5)

DOI: 10.1111/dar.70211 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Drug and Alcohol Review, online erschienen am 22.07.2026. Verfasst von Chris Tremonti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Alcohol and Drug Services, St Vincent's Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Analgesics, Opioid, Buprenorphine, Methadone, Opiate Substitution Treatment. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Methadone‐to‐buprenorphine transfers (MBT) are increasingly common as buprenorphine use expands. Evidence describing patient experience of withdrawal during MBT in real‐world populations is limited. This study aimed to characterise withdrawal trajectories during MBT and examine whether psychosocial and clinical factors influence the severity or timing of withdrawal.

Methods

This analysis used data from a prospective, non‐randomised clinical trial comparing low‐dose and stop‐and‐start MBT techniques ( n = 117). Covariates included methadone dose, duration on methadone, transfer setting, study arm, withdrawal expectancy, psychological distress, substance use and unstable housing. Withdrawal was assessed daily using the Clinical Opioid Withdrawal Scale (COWS) and Short Opiate Withdrawal Scale.

Results

Ninety‐four participants (80.3%) completed transfer. Withdrawal followed a consistent trajectory across the cohort, peaking around Day 5. Psychosocial and clinical characteristics—including unstable housing, substance use, psychological distress and methadone dose—were not associated with withdrawal severity or timing. Compared with stop‐and‐start transfer, low‐dose transfer was associated with a delayed and larger increase in objective withdrawal: peak COWS occurred 2.3 days later (95% CI 0.3–4.3) and the largest one‐day increase was 3.8 points higher (95% CI 0.5–7.0). Discussion and Conclusions Patient factors often considered barriers to MBT were not associated with withdrawal severity or timing. Low‐dose transfer was associated with a delayed and slightly higher withdrawal peak but did not reduce overall transfer success. These findings suggest that withdrawal during MBT follows a broadly similar trajectory across patients with differing psychosocial complexity. Planning for expected withdrawal, rather than selecting patients based on perceived complexity, may be more clinically relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidBuprenorphineMethadoneOpiate Substitution TreatmentSubstance Withdrawal SyndromeDrug SubstitutionAdultFemaleHumansMaleMiddle AgedAustraliaOpioid-Related DisordersProspective StudiesPsychological Distress

Stichwörter der Autor:innen

buprenorphine inductionbuprenorphine transfermethadoneopioid use disorderpatient‐centred outcomeswithdrawal trajectory

Substanzen

Analgesics, OpioidBuprenorphineMethadone

Autor:innen und Institutionen

  • Alcohol and Drug Services, St Vincent's Hospital, Sydney, Australia.
  • Drug Health Services, Sydney Local Health District, Sydney, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, Australia.
  • NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN), Sydney, Australia.
  • Southern NSW Local Health District Alcohol and Other Drug Services, Queanbeyan, Australia.

ORCID-Profile: Chris Tremonti, James Blogg, Mark Montebello, Robert Page, Varan Perananthan

Zitieren

APA

Tremonti, C., Mills, L., Lintzeris, N., Blogg, J., Jamshidi, N., Harjanto, R., Blazey, A., Montebello, M., Ismay, C., Page, R., Buckley, N. A., Perananthan, V., & Haber, P. S. (2026). Patient Experience of Withdrawal During Methadone–Buprenorphine Transfer: A Prospective Cohort Study. Drug and Alcohol Review, 45(5). https://doi.org/10.1111/dar.70211

Vancouver

Tremonti C, Mills L, Lintzeris N, Blogg J, Jamshidi N, Harjanto R, et al. Patient Experience of Withdrawal During Methadone–Buprenorphine Transfer: A Prospective Cohort Study. Drug and Alcohol Review. 2026;45(5). doi:10.1111/dar.70211

BibTeX
@article{Tremonti2026,
  author = {Tremonti, Chris and Mills, Llewellyn and Lintzeris, Nicholas and Blogg, James and Jamshidi, Nazila and Harjanto, Ricky and Blazey, Alison and Montebello, Mark and Ismay, Charlotte and Page, Robert and Buckley, Nicholas A and Perananthan, Varan and Haber, Paul S},
  title = {Patient Experience of Withdrawal During Methadone–Buprenorphine Transfer: A Prospective Cohort Study},
  journal = {Drug and Alcohol Review},
  year = {2026},
  volume = {45},
  number = {5},
  doi = {10.1111/dar.70211}
}
Kostenlos starten →